Health Care AcceptorNCT04802512
Turkish Version of Telehealth Usability Questionnaire (TUQ)
An observational study of Health Care Acceptor and Health Knowledge, Attitudes, Practice, run by Irem Hüzmeli at 2 sites in Turkey (Türkiye).
Trial summary
The Telehealth Usability Questionnaire (TUQ) was developed to evaluate the usability of telehealth applications and services. The Turkish validity and reliability study of the scale, originally in English, has not been conducted before. Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- Health Care Acceptor, Health Knowledge, Attitudes, Practice, Patient Participation
- What is being tested?
- validity and reability study
- Type of treatment
- Surgery or procedure
- How many people
- 170 participants
- Where
- 2 sitesTurkey (Türkiye)
- Study dates
- 12 Mar 2021to 12 Jun 2022
- How long will I take part?
- 15 Days
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Study population: The Turkish validity and reliability of the scale, which was created to evaluate the usability of the telehealth service for service users (patients) and providers (health professional), will be investigated.
Who may be able to join
- Participants will undergo screening to confirm eligibility, completion of initial screening form, and MMSE evaluation. Study subjects were enrolled with MMSE scores between 29-30, inclusive (healthy/control), 25-28, inclusive (mild cognitive impairment), and 10-24 (dementia).
- -
Who cannot join
- Unable to complete computerized and standard pencil-and-paper based assessments
Trial locations and contacts
2 sites in 1 country.
Turkey (Türkiye)2 sites
Hatay Mustafa Kemal University
Hatay, Merkez, 31010
Online
Hatay
About this study
Official title: Investigation of the Turkish Validity and Reliability of the Telehealth Usability Questionnaire (TUQ)
The Telehealth Usability Questionnaire (TUQ) was developed to evaluate the usability of telehealth applications and services. The Turkish validity and reliability study of the scale, originally in English, has not been conducted before.
The aim of this study is to develop the Turkish version of the Telehealth Usability Questionnaire (TUQ), which is a new stability tool, and to report its reliability assessment.
Read the detailed description
The Telehealth Usability Questionnaire (TUQ) turkish version will be asked by using google forms to participants whom use telehealth.
- Being tested
- validity and reability study
- Medical subject headings
- Patient Acceptance of Health Care, Behavior, Patient Participation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
validity and reability studyProcedure or surgery
validity and reliability assessment of the Turkish version of the Telehealth Usability Questionnaire (TUQ)
| Study group | Role | What they receive |
|---|---|---|
| patients | patients who were used telehealth Receives: Procedure: validity and reability study | |
| health professional | health professional who were used telehealth. Receives: Procedure: validity and reability study |
What is being measured
The primary outcome is the main question the study is designed to answer.
Reliability and Validity of TUQ by Correlation Analysis.
with telehealth will be researched
Measured: 12 month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Mar 2021
- Study start12 Mar 2021
- Primary completion12 Jun 2022
- Study completion12 Jun 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Health Care AcceptorStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Enrolment
- 170 participants (actual)
- Target duration
- 15 Days
Sponsor and investigators
- Lead sponsor
- Irem Hüzmeli
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Irem Hüzmeli, Mustafa Kemal University
- Investigators
- Irem Huzmeli, Phd, Study director, Mustafa Kemal UniversityEsra Dogru Huzmeli, Assoc Prof., Principal investigator, Mustafa Kemal UniversityMehmet Karadağ, Asist. Prof., Study chair, Mustafa Kemal University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04802512
- Sponsor's protocol ID
- HatayMustafaKU
- Status last verified
- Dec 2023
- First submitted
- 14 Mar 2021
- Last updated
- 5 Dec 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 5 Dec 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Investigation of the Turkish Validity and Reliability of the Telehealth Usability Questionnaire (TUQ)
- ClinicalTrials.gov ID
- NCT04802512
- Acronym / sponsor ID
- HatayMustafaKU
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 170 participants (actual)
- Lead sponsor
- Irem HüzmeliUniversity, hospital or other
- Study start
- 12 Mar 2021 (actual)
- Primary completion
- 12 Jun 2022 (actual)
- Study completion
- 12 Jun 2022 (actual)
- First posted
- 17 Mar 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The Telehealth Usability Questionnaire (TUQ) was developed to evaluate the usability of telehealth applications and services. The Turkish validity and reliability study of the scale, originally in English, has not been conducted before.
The aim of this study is to develop the Turkish version of the Telehealth Usability Questionnaire (TUQ), which is a new stability tool, and to report its reliability assessment.
Detailed description
The Telehealth Usability Questionnaire (TUQ) turkish version will be asked by using google forms to participants whom use telehealth.
Study design
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Target follow-up
- 15 Days
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| patients | – | Procedure: validity and reability studypatients who were used telehealth |
| health professional | – | Procedure: validity and reability studyhealth professional who were used telehealth. |
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
- Study population
- The Turkish validity and reliability of the scale, which was created to evaluate the usability of the telehealth service for service users (patients) and providers (health professional), will be investigated.
Key inclusion criteria (2 listed)
- Participants will undergo screening to confirm eligibility, completion of initial screening form, and MMSE evaluation. Study subjects were enrolled with MMSE scores between 29-30, inclusive (healthy/control), 25-28, inclusive (mild cognitive impairment), and 10-24 (dementia).
- -
Key exclusion criteria (1 listed)
- Unable to complete computerized and standard pencil-and-paper based assessments
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| validity and reability studyvalidity and reliability assessment of the Turkish version of the Telehealth Usability Questionnaire (TUQ) | Procedure or surgery | health professional, patients |
Primary outcome
Reliability and Validity of TUQ by Correlation Analysis.
Time frame: 12 month
with telehealth will be researched
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Dec 2023.
- Individual participant dataSharing planned: Undecided
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Irem Huzmeli, Phd study director
Mustafa Kemal University
Esra Dogru Huzmeli, Assoc Prof. principal investigator
Mustafa Kemal University
Mehmet Karadağ, Asist. Prof. study chair
Mustafa Kemal University
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Health Care Acceptor and Health Knowledge, Attitudes, Practice, run by Irem Hüzmeli at 2 sites in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 5 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Reliability and Validity of TUQ by Correlation Analysis. (time frame: 12 month). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Dec 2023.